The complexity of the cardio-renal link: Taxonomy, syndromes, and diseases

Kidney International Supplements

Volumn 1, Issue 1, 2011, Pages 2-5

  Zoccali, Carmine ^a   Goldsmith, David ^b   Agarwal, Rajiv ^c   Blankestijn, Peter J ^d   Fliser, Danilo ^e   Wiecek, Andrzej ^f   Suleymanlar, Gultekin ^g   Ortiz, Alberto ^h   Massy, Ziad ^i,j   Covic, Adrian ^k   Martinez Castelao, Alberto ^l   Jager, Kitty J ^m   Dekker, Friedo W ⁿ   Lindholm, Bengt ^o   London, Gerard ^p  

^a CNR   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e SAARLAND UNIVERSITY   (Germany)

^f MEDICAL UNIVERSITY OF SILESIA   (Poland)

^g AKDENIZ UNIVERSITY   (Turkey)

^h UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

ⁱ INSERM   (France)

^j AMIENS UNIVERSITY HOSPITAL   (France)

^k C I PARHON NATIONAL INSTITUTE OF ENDOCRINOLOGY   (Romania)

^l HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^m UNIVERSITY OF AMSTERDAM   (Netherlands)

ⁿ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^o KAROLINSKA INSTITUTE   (Sweden)

^p PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

more..

Author keywords

cardio renal; cardiovascular risk; CKD; death; ESRD; progression of CKD

Indexed keywords

EID: 84861026739     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2011.4     Document Type: Review

References (35)

1. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117.
2. Zoccali C, Kramer A, Jager KJ. Epidemiology of CKD in Europe: an uncertain scenario. Nephrol Dial Transplant 2010; 25: 1731-1733.
3. Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663. (Pubitemid 38392981)
4. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Q 2005; 83: 731-757. (Pubitemid 43127784)
5. Matsushita K, van der Velde M, Astor BC et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081.
6. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
7. Amann K, Wiest G, Zimmer G et al. Reduced capillary density in the myocardium of uremic rats-a stereological study. Kidney Int 1992; 42: 1079-1085.
8. Bro S, Bentzon JF, Falk E et al. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. J Am Soc Nephrol 2003; 14: 2466-2474. (Pubitemid 37169332)
9. Massy ZA, Ivanovski O, Nguyen-Khoa T et al. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 2005; 16: 109-116. (Pubitemid 43073162)
10. van Dokkum RP, Eijkelkamp WB, Kluppel AC et al. Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction. J Am Soc Nephrol 2004; 15: 3103-3110. (Pubitemid 39578842)
11. Hillege HL, van Gilst WH, Van Veldhuisen DJ et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J 2003; 24: 412-420. (Pubitemid 36286184)
12. Magri P, Rao MA, Cangianiello S et al. Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism. Circulation 1998; 98: 2849-2854. (Pubitemid 29003966)
13. Cody RJ, Ljungman S, Covit AB et al. Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int 1988; 34: 361-367.
14. Damman K, van DV, Navis G et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009; 53: 582-588.
15. Jafar TH, Stark PC, Schmid CH et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003; 139: 244-252.
16. Flather MD, Yusuf S, Kober L et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000; 355: 1575-1581. (Pubitemid 30240501)
17. Lewis T. Paroxysmal dyspnoea in cardiorenal patients: with particular reference to 'cardiac' and 'uremic' asthma. Br Med J 1913; 29: 1417-1420.
18. Bock JS, Gottlieb SS. Cardiorenal syndrome: new perspectives. Circulation 2010; 121: 2592-2600.
19. Ronco C, Haapio M, House AA et al. Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527-1539.
20. National Heart, Lung and Blood Institute (NHLBI) working group. Cardiorenal connections in heart failure and cardiovascular disease. 20-8-2004. http://www.nhlbi.nih.gov/meetings/workshops/cardiorenal-hf-hd.htm. Accessed 20 December 2010.
21. Testani JM, Chen J, McCauley BD et al. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010; 122: 265-272.
22. Besarab A, Horl WH, Silverberg D. Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome. Oncologist 2009; 14(Suppl 1): 22-33.
23. Keane WF. Metabolic pathogenesis of cardiorenal disease. Am J Kidney Dis 2001; 38: 1372-1375. (Pubitemid 34193129)
24. de Mutsert R, Grootendorst DC, Axelsson J et al. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant 2008; 23: 2957-2964.
25. Levy WC, Mozaffarian D, Linker DT et al. The seattle heart failure model: prediction of survival in heart failure. Circulation 2006; 113: 1424-1433. (Pubitemid 43739439)
26. Lee DS, Austin PC, Rouleau JL et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003; 290: 2581-2587. (Pubitemid 37443288)
27. Jessup M, Abraham WT, Casey DE et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977-2016.
28. Grundy SM, Brewer Jr HB, Cleeman JI et al Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
29. Simmons RK, Alberti KG, Gale EA et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010; 53: 600-605.
30. Lusis AJ, Attie AD, Reue K. Metabolic syndrome: from epidemiology to systems biology. Nat Rev Genet 2008; 9: 819-830.
31. Wheelock CE, Wheelock AM, Kawashima S et al. Systems biology approaches and pathway tools for investigating cardiovascular disease. Mol Biosyst 2009; 5: 588-602.
32. Lauer MS, Skarlatos S. Translational research for cardiovascular diseases at the National Heart, Lung, and Blood Institute: moving from bench to bedside and from bedside to community. Circulation 2010; 121: 929-933.
33. de Jager DJ, Grootendorst DC, Jager KJ et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302: 1782-1789.
34. Bart BA. Treatment of congestion in congestive heart failure: ultrafiltration is the only rational initial treatment of volume overload in decompensated heart failure. Circ Heart Fail 2009; 2: 499-504.
35. Shin JT, Dec GW. Ultrafiltration should not replace diuretics for the initial treatment of acute decompensated heart failure. Circ Heart Fail 2009; 2: 505-511.